AdarshMotwani

AdarshMotwani

A week ahead of the results, the energy-centric company took a toll in lieu of the last trading session's underlying event. However, that doesn't deter the pent up short-cycle orders the company has been reaping on for the last few years. This alone can become a pivot of sustenance against the competitors. Now, pit this sentiment against the global cues of the...

AdarshMotwani Updated 

Pharma sector constituents are under good traction, whether they are directly racing to find the cure for COVID-19 or just acting as an ancillary medium to main players. Technically, Lupin in particular, after getting out of a constricted regression channel, is in a bull drive with a healthy flag and now halted at a pennant. Here, Volumes are imbalanced both in...

AdarshMotwani Updated 

At large the stock is in a continuation phase currently and is expected to consolidate further given its possible pennant structure. However, the supply zone has been tested multiple times in the last 7 trading sessions combined with higher lows at each test. This may cause an untimely break in the following trading session which in turn will provide a good...

AdarshMotwani Updated 

Based on Market sentiment there is a long bias being observed in the stock. Daily key levels are marked with the blue breach of which can initiate a fresh trend. While the yellow zones are respectively the immediate demand and supply zones. Constricted CPR suggests a strong trend in the following trading session. Lastly, the volume squeeze seem ready to be...

AdarshMotwani Updated 

There's an expected strong intraday momentum for the following trading session due to the listed factors: 1. Ongoing Market Volatility 2. Long weekend trading order absorption 3. Continuation pattern peaking in the continuing downtrend 4. Demand and Supply zoned followed by low volume clusters outside value area i.e. any breach has no obstruction from forming a...